• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. IMPRA® EPTFE VASCULAR GRAFTS; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. IMPRA® EPTFE VASCULAR GRAFTS; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Model Number CFT4547C
Device Problem Output Problem (3005)
Patient Problems Hemorrhage/Bleeding (1888); Unspecified Mental, Emotional or Behavioural Problem (4430)
Event Date 02/23/2022
Event Type  malfunction  
Event Description
This is an (b)(6) year-old gentleman who has had a left upper arm av graft for a few years and was noted to have a defect, possibly in the mid portion of the graft with a "bubble" that was concerning for possible infection and risk of bleeding.He has had a little bit of oozing from the area, but the graft has been used without difficulty and the patient had no evidence of bacteremia or gross infection.The affected area seems to have worsened over time.The patient was advised on multiple occasions to see me for evaluation and possible treatment of this issue, but now that he is hospitalized for mental status changes it was felt that he could be seen and treated as well as needed.  description of procedure: the patient was taken to the operating room and given iv ancef for antibiotic prophylaxis.His left arm was prepped and draped in the usual fashion.A tourniquet was present in the room.After a timeout was performed, we injected the skin surrounding the affected area with 1% lidocaine and the patient was sedated.An ellipse was made around the affected area and revealed a hole in the graft.We obtained manual pressure and the patient was given 3000 units of iv heparin.Three minutes later, a sterile tourniquet was applied close to the axilla to stop oozing and bleeding and it was then inflated to 250 mmhg after with the patient's arm was esmarched.No further bleeding was noted and we noted there was a large defect in the graft that could not be salvaged and by definition this is an infected graft, so that portion was excised, but to gain control proximally and distally we needed to find healthy graft to ligate.This was done proximally towards the arterial portion of the graft and distally towards the venous end of the graft where 0 silk ligatures were applied after mobilization of the graft was performed.All wounds were irrigated with ancef and closed in layers including inverted interrupted 3-0 vicryl sutures to approximate subcutaneous tissue, followed by 3-0 nylon mattress sutures for skin closure.Only the portion of the graft affected by the defect was removed.The rest of the graft was ligated.Sterile dressing was applied and an arm brace was applied loosely to prevent the patient from bending his arm.Good distal perfusion was noted.The patient tolerated the procedure well and was transferred to recovery room in stable condition.Blood loss was 50 ml.All counts were correct at the end the case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPRA® EPTFE VASCULAR GRAFTS
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w. 3rd st
tempe AZ 85281
MDR Report Key13757298
MDR Text Key287129500
Report Number13757298
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberCFT4547C
Device Catalogue NumberCFT4547C
Device Lot NumberVTCQ0450
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA02/28/2022
Device Age3 YR
Event Location Hospital
Date Report to Manufacturer03/14/2022
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/14/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Age29565 DA
Patient SexMale
Patient Weight77 KG
Patient RaceBlack Or African American
-
-